Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pyoderma”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649
What this trial is testing

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

Who this might be right for
Post-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more
Jay C. Buckey Jr. 100
Not applicableStudy completedNCT00791557
What this trial is testing

Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease

Who this might be right for
Pyoderma GangrenosumCrohn's DiseaseUlcerative Colitis+1 more
University Hospitals Cleveland Medical Center 2
Testing effectiveness (Phase 2)WithdrawnNCT00690846
What this trial is testing

Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Study completedNCT01302795
What this trial is testing

Canakinumab for Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
University of Zurich 5
Testing effectiveness (Phase 2)Study completedNCT03971643
What this trial is testing

Exploratory Study of IFX-1 in Patients With Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
InflaRx GmbH 19
Testing effectiveness (Phase 2)Ended earlyNCT03072953
What this trial is testing

Efficacy and Safety of APD334 in Patients With Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Arena Pharmaceuticals 2
Testing effectiveness (Phase 2)Study completedNCT03137160
What this trial is testing

An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Ohio State University 4
Very early researchWithdrawnNCT05821374
What this trial is testing

Deucravacitinib in PG

Who this might be right for
Pyoderma Gangrenosum
Dartmouth-Hitchcock Medical Center
Large-scale testing (Phase 3)Looking for participantsNCT06624670
What this trial is testing

Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Boehringer Ingelheim 90
Early research (Phase 1)Study completedNCT03386942
What this trial is testing

MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin) in Participants With Solid Tumors

Who this might be right for
Solid Tumors
Eisai Inc. 82
Post-approval studies (Phase 4)WithdrawnNCT00202891
What this trial is testing

Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460)

Who this might be right for
Pyoderma
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06563323
What this trial is testing

Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)

Who this might be right for
Pyoderma GangrenosumSkin DiseasesWound Heal+2 more
Oregon Health and Science University 17
Large-scale testing (Phase 3)Ended earlyNCT02315417
What this trial is testing

An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
XOMA (US) LLC 16
Not applicableUnknownNCT03636737
What this trial is testing

Study on the Clinical Features, Comorbidities and Pathologies Associated With Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Assistance Publique Hopitaux De Marseille 140
Testing effectiveness (Phase 2)Study completedNCT02733094
What this trial is testing

Single-arm Study to Assess a Potential Effect of Anti-IL-17 (Secukinumab) in the Treatment of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Technical University of Munich 8
Large-scale testing (Phase 3)Study completedNCT03311464
What this trial is testing

A Study Assessing the Efficacy and Safety of Adalimumab in Active Ulcer(s) of Pyoderma Gangrenosum in Participants in Japan

Who this might be right for
Pyoderma Gangrenosum
AbbVie 22
Large-scale testing (Phase 3)Ended earlyNCT02318914
What this trial is testing

A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
XOMA (US) LLC 15
Not applicableLooking for participantsNCT02280733
What this trial is testing

A Real-World Registry of Chronic Wounds and Ulcers

Who this might be right for
Diabetic FootPressure UlcerSurgical Wound Dehiscence+17 more
U.S. Wound Registry 300,000
Testing effectiveness (Phase 2)Ended earlyNCT06092216
What this trial is testing

Spesolimab in Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Icahn School of Medicine at Mount Sinai 5
Not applicableStudy completedNCT00284882
What this trial is testing

Incidence of Group A Strep Pharyngitis in School Children in Fiji

Who this might be right for
Streptococcus Group A
National Institute of Allergy and Infectious Diseases (NIAID) 1,000
Load More Results